CA2186760C - Utilisation de biopolymeres pour le traitement des muscles - Google Patents

Utilisation de biopolymeres pour le traitement des muscles Download PDF

Info

Publication number
CA2186760C
CA2186760C CA002186760A CA2186760A CA2186760C CA 2186760 C CA2186760 C CA 2186760C CA 002186760 A CA002186760 A CA 002186760A CA 2186760 A CA2186760 A CA 2186760A CA 2186760 C CA2186760 C CA 2186760C
Authority
CA
Canada
Prior art keywords
use according
polymer
cmdbs
muscle
polysaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002186760A
Other languages
English (en)
French (fr)
Other versions
CA2186760A1 (fr
Inventor
Denis Barritault
Jean-Pierre Caruelle
Pascal Desgranges
Jean Gautron
Anne Meddahi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Valbiofrance Ste
Original Assignee
Valbiofrance Ste
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valbiofrance Ste filed Critical Valbiofrance Ste
Publication of CA2186760A1 publication Critical patent/CA2186760A1/fr
Application granted granted Critical
Publication of CA2186760C publication Critical patent/CA2186760C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
CA002186760A 1994-03-30 1995-03-29 Utilisation de biopolymeres pour le traitement des muscles Expired - Fee Related CA2186760C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9403803A FR2718026B1 (fr) 1994-03-30 1994-03-30 Médicament et composition pharmaceutique pour le traitement des muscles.
FR94/03803 1994-03-30
PCT/FR1995/000398 WO1995026736A1 (fr) 1994-03-30 1995-03-29 Utilisation de biopolymeres pour le traitement des muscles

Publications (2)

Publication Number Publication Date
CA2186760A1 CA2186760A1 (fr) 1995-10-12
CA2186760C true CA2186760C (fr) 2007-10-30

Family

ID=9461614

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002186760A Expired - Fee Related CA2186760C (fr) 1994-03-30 1995-03-29 Utilisation de biopolymeres pour le traitement des muscles

Country Status (9)

Country Link
US (1) US5852003A (es)
EP (1) EP0752862B1 (es)
JP (1) JPH10503472A (es)
AT (1) ATE243521T1 (es)
CA (1) CA2186760C (es)
DE (1) DE69531150T2 (es)
ES (1) ES2202358T3 (es)
FR (1) FR2718026B1 (es)
WO (1) WO1995026736A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2781375A1 (fr) * 1998-07-21 2000-01-28 Denis Barritault Composition anti-fibrotique contenant des polymeres ou biopolymeres et leurs utilisations
FR2781485B1 (fr) 1998-07-21 2003-08-08 Denis Barritault Polymeres biocompatibles leur procede de preparation et les compositions les contenant
FR2781374B1 (fr) * 1998-07-21 2001-06-29 Denis Barritault Composition antioxydante comprenant au moins un polymere ou biopolymere seul ou associe a la sod
FR2794976B1 (fr) 1999-06-16 2004-05-07 Solutions Compositions pharmaceutiques a action cicatrisante ou anti-complementaire comprenant un derive de dextrane
AU2001296915A1 (en) * 2000-09-26 2002-04-08 Sidney Kimmel Cancer Center Inhibition of antigen presentation with poorly catabolized polymers
FR2861308A1 (fr) 2003-10-28 2005-04-29 Organes Tissus Regeneration Re Utilisation de polymeres biocompatibles pour la preparation d'une composition pharmaceutique, dermatologique ou cosmetique destinee a la prevention, au soulagement ou au traitement des genes, desagrements et douleurs
ES2552106T3 (es) 2003-10-28 2015-11-25 Organes Tissus Régénération Réparation Remplacement Polímeros biocompatibles para una composición médica
FR2907014B1 (fr) * 2006-10-17 2009-05-15 Engelhard Lyon Sa Utilisation d'actifs cosmetiques pour proteger le fibroblaste growth factor-beta ou fgf-2 de la matrice extracellulaire dans le but de restructurer cette matrice
FR2914191A1 (fr) * 2007-03-29 2008-10-03 Proteins & Peptides Man Composition angiogenique.
US8193220B1 (en) * 2009-08-20 2012-06-05 Alan Brown Scott Method of changing muscle lengths with anesthetic drugs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2461724A1 (fr) * 1979-07-20 1981-02-06 Christine Fougnot Polymeres substitues par des groupes leur conferant des proprietes anti-coagulantes et leur procede de preparation, objets constitues par et/ou comprenant lesdits polymeres et leurs procedes de fabrication, application desdits objets en chirurgie et en medecine, et compositions pharmaceutiques contenant lesdits polymeres substitues
FR2555589B1 (fr) * 1983-11-30 1986-05-16 Choay Sa Nouveaux derives du dextrane a activites anticoagulante en anti-inflammatoire, leur procede de preparation et utilisation de ces derives en tant qu'anticoagulants et en tant que substituts du plasma sanguin
FR2644066B1 (fr) * 1989-03-09 1994-05-13 Therapeutiques Substitutives Compositions stabilisees comprenant des fgfs, leur procede d'obtention et leurs applications therapeutiques, chirurgicales et cosmetologiques

Also Published As

Publication number Publication date
WO1995026736A1 (fr) 1995-10-12
US5852003A (en) 1998-12-22
EP0752862B1 (fr) 2003-06-25
ES2202358T3 (es) 2004-04-01
DE69531150D1 (de) 2003-07-31
ATE243521T1 (de) 2003-07-15
DE69531150T2 (de) 2004-04-29
JPH10503472A (ja) 1998-03-31
EP0752862A1 (fr) 1997-01-15
CA2186760A1 (fr) 1995-10-12
FR2718026B1 (fr) 1997-01-17
FR2718026A1 (fr) 1995-10-06

Similar Documents

Publication Publication Date Title
EP1117695B1 (fr) Polymeres biocompatibles, les compositions les contenant et leur utilisation pour la préparation de médicaments
JP2021042238A (ja) バイオコンジュゲートおよびその使用
CA2186757C (fr) Utilisation de biopolymeres pour le traitement de lesions du tractus digestif
CA2186760C (fr) Utilisation de biopolymeres pour le traitement des muscles
US6489311B1 (en) Method for the prevention of apoptosis
EP0208623A2 (fr) Utilisation de poly- et oligosaccharides pour l'obtention de médicaments actifs dans les pathologies du tissu conjonctif
DE69838732T2 (de) Heparinähnliche verbindungen, ihre herstellung und verwendung zur verhinderung arterieller thrombose, verbunden mit vaskulärer verletzung und eingriffen
EP0462194B1 (fr) Compositions stabilisees a base de fgf
AU2001259811A1 (en) Method for the prevention of apoptosis
FR2485019A1 (fr) Glucosaminoglycanes modifies possedant une activite antilipemique et pratiquement exempts d'une activite anti-coagulante
EP1406637B1 (fr) Compositions pharmaceutiques a action cicatrisante ou anti-complementaire comprenant un derive de dextrane
EP0752865B1 (fr) Utilisation de dextrane substitue pour le traitement des lesions du systeme nerveux et fractions enrichies en herapane sulfate
HUT76895A (en) Use of hyaluronic acid for preparing pharmaceutical compns. for treatment of disease and conditions associated with macrophage infiltration
CA2186758A1 (fr) Utilisation des polymeres protegeant des facteurs de croissance pour le traitement de l'inflammation
JPH06312941A (ja) Ｈｇｆ産生促進剤
US6313104B1 (en) Organoprotective solutions
JP2001514629A (ja) 薬剤製造へのヒトα▲下１▼−酸性糖蛋白質の使用法
WO1994004175A1 (en) Hgf production promoter

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20140402